VentiV Scientific

VentiV Scientific is a private, commercial-stage medical device company based in San Diego, founded in 2018, specializing in innovative thrombectomy technologies. Its core innovation, the V-Pulse™ system, is an FDA-cleared, pump-agnostic device that delivers pulsed, surgeon-controlled aspiration directly at the catheter tip, aiming to improve procedural efficiency and reduce blood loss. With over 15,000 devices sold globally and a portfolio of 50+ FDA/CE-cleared devices, the company is positioned in the large and growing clot management market. VentiV leverages a diversified platform of thrombectomy systems and catheters, supported by established manufacturing and clinical data.

The V-Pulse™ platform is a mechanical thrombectomy system engineered for instant, tip-level suction with controlled, pulsed clot engagement. Its core technology features a thumb-activated control for immediate on/off suction, an anti-clogging piston mechanism, and pump-agnostic compatibility with any hospital suction source.

VentiV operates in the competitive mechanical and aspiration thrombectomy market, competing against large-cap medtech companies (e.g., Boston Scientific, Medtronic, Penumbra) and specialized players. Its key differentiation is the instant, pulsed tip-control and anti-clogging mechanism without a proprietary console. Success hinges on proving clinical advantages in blood loss reduction and procedural efficiency over existing solutions.